These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27560702)

  • 1. Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung.
    Campbell J; Nys J; Eghobamien L; Cohen ES; Robinson MJ; Sleeman MA
    MAbs; 2016 Oct; 8(7):1398-1406. PubMed ID: 27560702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.
    Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA
    Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.
    Greven DE; Cohen ES; Gerlag DM; Campbell J; Woods J; Davis N; van Nieuwenhuijze A; Lewis A; Heasmen S; McCourt M; Corkill D; Dodd A; Elvin J; Statache G; Wicks IP; Anderson IK; Nash A; Sleeman MA; Tak PP
    Ann Rheum Dis; 2015 Oct; 74(10):1924-30. PubMed ID: 24936585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safety.
    Ryan PC; Sleeman MA; Rebelatto M; Wang B; Lu H; Chen X; Wu CY; Hinrichs MJ; Roskos L; Towers H; McKeever K; Dixit R
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):230-9. PubMed ID: 24937321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
    Corkill DJ; Hunt AN; Hinrichs MJ; White N; Rebelatto M; Roskos L; Nys J; Scott A; Robinson MJ; Ryan P; Postle AD; Sleeman MA
    Clin Sci (Lond); 2021 Nov; 135(22):2559-2573. PubMed ID: 34778899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil GM-CSF receptor dynamics in acute lung injury.
    De Alessandris S; Ferguson GJ; Dodd AJ; Juss JK; Devaprasad A; Piper S; Wyatt O; Killick H; Corkill DJ; Cohen ES; Pandit A; Radstake TRDJ; Simmonds R; Condliffe AM; Sleeman MA; Cowburn AS; Finch DK; Chilvers ER
    J Leukoc Biol; 2019 Jun; 105(6):1183-1194. PubMed ID: 30942918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
    Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
    Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
    Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
    Guo X; Higgs BW; Bay-Jensen AC; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Rheumatology (Oxford); 2018 Jan; 57(1):175-184. PubMed ID: 29069507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting GM-CSF in rheumatoid arthritis.
    Avci AB; Feist E; Burmester GR
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):39-44. PubMed ID: 27586802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice.
    Zsengellér ZK; Reed JA; Bachurski CJ; LeVine AM; Forry-Schaudies S; Hirsch R; Whitsett JA
    Hum Gene Ther; 1998 Sep; 9(14):2101-9. PubMed ID: 9759936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
    Tazawa R; Nakata K; Inoue Y; Nukiwa T
    Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chang GD; Chern MS; Chen YC; Chang SC
    Thorax; 2006 Jun; 61(6):528-34. PubMed ID: 16517574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
    Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
    Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic modeling of antigen sink effect for mavrilimumab following intravenous administration in patients with rheumatoid arthritis.
    Wang B; Lau YY; Liang M; Vainshtein I; Zusmanovich M; Lu H; Magrini F; Sleeman M; Roskos L
    J Clin Pharmacol; 2012 Aug; 52(8):1150-61. PubMed ID: 21947370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFRα-mAb treatment in rheumatoid arthritis patients.
    Mortensen JH; Guo X; De Los Reyes M; Dziegiel MH; Karsdal MA; Bay-Jensen AC; White WI
    Clin Exp Rheumatol; 2019; 37(1):73-80. PubMed ID: 30418117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
    Huizar I; Kavuru MS
    Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-3, IL-5, granulocyte-macrophage colony-stimulating factor receptor alpha-subunit, and common beta-subunit expression by peripheral leukocytes and blood dendritic cells.
    Yamada T; Sun Q; Zeibecoglou K; Bungre J; North J; Kay AB; Lopez AF; Robinson DS
    J Allergy Clin Immunol; 1998 May; 101(5):677-82. PubMed ID: 9600506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
    Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
    J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome.
    Papoff P; Christensen RD; Calhoun DA; Juul SE
    Biol Neonate; 2001 Aug; 80(2):133-41. PubMed ID: 11509813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.